| To view this email as a web page, click here.
|
 |
| |
| Dear (Auto populate name, if possible) |
| |
| In an all virtual world it can be challenging to connect with the top minds in oncology. We’re here to help you overcome this challenge by leveraging our connections with top tier KOLs, Community Practitioners, Provider Networks, and Physician Networks through the industry’s leading advisory boards and publications, available exclusively from OncLive®. |
| |
| Virtual Advisory Boards |
| The solution we provide |
- Full meeting and logistics management
- Recruitment of leading experts
- Content Development
- Post event Executive Summary
|
| |
| How you benefit |
- Connect thought leaders virtually to review scientific rationale and clinical data for developmental compounds and all insights into all stages of marketed drugs
- Gain feedback on disease state and market trends in cancer, including how drug candidates may fit into the treatment armamentarium
- Receive input on product profiles and lifecycle management for marketed drugs
|
| |
| Engage with oncology healthcare professionals to develop a deeper understanding of a specific tumor type and/or therapeutic area treatment. |
| |
 |
| |
| Covering every angle of oncology practice |
| |
 |
OncologyLive® is a twice-monthly clinical news publication with a 20,000- plus circulation and provides community oncologists and hematologists with:
- Up-to-date information and expert insights that help translate research developments into clinical practice.
- In-depth reporting about trends in the oncology field
- A detailed look at newly approved cancer drugs and indications
- Highlights from conferences throughout the world
- Practice management advice
|
|
| Learn about these and other leading publications we produce to keep the oncology community informed and leverage our multichannel communication capabilities. |
| |
|
| |
| Please note MJH Life Sciences™ has announced that all conferences, satellite symposia, award programs, and educational programming will take place in a virtual format through March 2021. |
| |
We look forward to being
Your Link to Everything Oncology. |
| |
|
|
